Associate Professor of Surgery
General Surgery
Dr. John W. Yim, MD
|
|
Give Review
Doctor John W. Yim, MD is an expert in the field of General Surgery. He went to Stanford University School of Medicine. Stanford University School of Medicine is a top medical university. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He over the years received 1 awards: "Fellow (FACS)". Dr. John W. Yim is a published MD. He published 60 publications, including: 'Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1.' John W. Yim, MD accepts Medicare.
Publications
- Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer.
- Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells.
- Pathologic complete response rates in triple-negative, HER2-positive, and hormone receptor-positive breast cancers after anthracycline-free neoadjuvant chemotherapy wi...
- Life Expectancy after Curative-intent Treatment of Breast Cancer: Impact on Long-term Follow-up Care.
- Evaluation of expert criteria for preoperative magnetic resonance imaging of newly diagnosed breast cancer.
- Interferon Regulatory Factor 1 (IRF-1) induces p21(WAF1/CIP1) dependent cell cycle arrest and p21(WAF1/CIP1) independent modulation of survivin in cancer cells.
- Identification of a Natural Compound by Cell-Based Screening that Enhances Interferon Regulatory Factor-1 Activity and Causes Tumor Suppression.
- Thyroid surgery and surgeons: the common interest.
- The adrenal mass: correlation of histopathology with imaging.
- Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.
- Sestamibi SPECT intensity scoring system in sporadic primary hyperparathyroidism.
- Localization of parathyroid adenomas by sonography and technetium tc 99m sestamibi single-photon emission computed tomography before minimally invasive parathyroidecto...
- Cystic parathyroid lesions: functional and nonfunctional parathyroid cysts.
- Tumor-to-tumor metastases to follicular variant of papillary thyroid carcinoma: histologic, immunohistochemical, and molecular studies of two unusual cases.
- Parathyroid lipoadenomas and lipohyperplasias: clinicopathologic correlations.
- Loss of heterozygosity of selected tumor suppressor genes in parathyroid carcinoma.
- Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism.
- Can a lightbulb sestamibi SPECT accurately predict single-gland disease in sporadic primary hyperparathyroidism?
- Same-day ultrasound guidance in reoperation for locally recurrent papillary thyroid cancer.
- The incidence of cancer and rate of false-negative cytology in thyroid nodules greater than or equal to 4 cm in size.
- Recurrent hyperparathyroidism secondary to parathyromatosis: clinical and imaging findings.
- Pathology quiz case 2. Parathyroid lipoadenoma.
- Fractional allelic loss of tumor suppressor genes identifies malignancy and predicts clinical outcome in follicular thyroid tumors.
- The transcription factor interferon regulatory factor-1 mediates liver damage during ischemia-reperfusion injury.
- Hyperthyroidism after parathyroid exploration.
- Allelic loss in parathyroid neoplasia can help characterize malignancy.
- Ectopic expression of interferon regulatory factor-1 promotes human breast cancer cell death and results in reduced expression of survivin.
- Loss of heterozygosity of the VHL gene identifies malignancy and predicts death in follicular thyroid tumors.
- The role of interferon regulatory factor-1 and interferon regulatory factor-2 in IFN-gamma growth inhibition of human breast carcinoma cell lines.
- Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.
- Involvement of retinoblastoma protein in p27Kip1-induced apoptosis.
- Cloning and structure of a rabbit protein inhibitor of neuronal nitric oxide synthase (PIN) gene and its pseudogene.
- In vivo and in vitro analyses of Myc for differential promoter activities of the human telomerase (hTERT) gene in normal and tumor cells.
- The putative tumor suppressor gene GLTSCR2 induces PTEN-modulated cell death.
- The binding of two dimers of IciA protein to the dnaA promoter 1P element enhances the binding of RNA polymerase to the dnaA promoter 1P.
- Human cytomegalovirus IE1 protein activates AP-1 through a cellular protein kinase(s).
- Unusual presentation of solitary cutaneous myxoma.
- High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12.
- The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.
- Epithelial cell-specific laminin 5 is required for survival of early thymocytes.
- Signaling pathways to the assembly of an interferon-beta enhanceosome. Chemical genetic studies with a small molecule.
- Identification of Mad as a repressor of the human telomerase (hTERT) gene.
- Molecular characterization of Drosophila melanogaster dihydropteridine reductase.
- Molecular characterization of Drosophila melanogaster myo-inositol-1-phosphate synthase.
- Activation of interferon regulatory factor 3 in response to DNA-damaging agents.
- Mammographically detected breast cancer. Benefits of stereotactic core versus wire localization biopsy.
- Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.
- Underlying pathology in mammary Paget's disease.
- Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-cJun NH2-terminal kinase pathway.
- IFN regulatory factor-1 gene transfer into an aggressive, nonimmunogenic sarcoma suppresses the malignant phenotype and enhances immunogenicity in syngeneic mice.
- Papillary thyroid cancer.
- Prospective study of the utility of somatostatin-receptor scintigraphy in the evaluation of patients with multiple endocrine neoplasia type 1.
- Enhancing in vivo tumorigenicity of B16 melanoma by overexpressing interferon regulatory factor-2: resistance to endogenous IFN-gamma.
- Appropriate surgical treatment of lithium-associated hyperparathyroidism.
- IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells.
- Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells.
- IFN-gamma enhances TRAIL-induced apoptosis through IRF-1.
- IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo.
- Ad-IRF-1 induces apoptosis in esophageal adenocarcinoma.
Schools
Boston University School Of Medicine
Albany Memorial Hospital
Brown University Ri Hospital
Boston Uboston Med Center
Doctors Specialties
- Diagnostic Radiology
- General Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
Washington University -
Stanford University School of Medicine
Hospital
-
City of Hope's Helford Clinical Research Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386722056 |
| Last Name Of The Provider | YIM |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Eugenio G. Amparo, MD |
|
|
Dr. Amir A. Amiri, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher Schaefer, MD |
|
Dr. Michael M. Aguilar, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Thiru T. Rajagopal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel L. Monahan, MD |
|
|
Dr. Hugo G. Bogren, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|